What is Morgan Stanley's price target for DOC?

Morgan Stanley's latest stated price target for Healthpeak Properties Inc. (DOC) is $22, from its action on Jun 11, 2026.

What is Morgan Stanley's rating on DOC?

Morgan Stanley rates DOC Equal-Weight, a neutral rating, as of Jun 11, 2026.

When did Morgan Stanley last change its view on DOC?

On Jun 11, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $22.

Analyst firms · Morgan Stanley · DOC

Morgan Stanley DOC price target and rating history

Healthpeak Properties Inc. (DOC) · Real Estate

Morgan Stanley rates Healthpeak Properties Inc. (DOC) Equal-Weight with a $22 price target, as of its latest action on Jun 11, 2026. It has published 6 rating actions on DOC since September 2021, including 1 upgrade and 3 downgrades. Across 6 firms with a DOC price target in the last 12 months, the median target is $19. Morgan Stanley's $22 is 16% above that.

Current rating: Equal-Weight
Price target: $22
Median target, all firms: $19
Actions on DOC: 6

Morgan Stanley price target on DOC

Morgan Stanley price target on DOC, each point a stated target, September 2021 to June 2026.

Every Morgan Stanley rating on DOC

Jun 11, 2026
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $22
Jan 15, 2025
UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $25
Mar 7, 2022
ReiterateMorgan Stanley cuts its price target to $18 from $19, keeps Equal-Weight
Nov 29, 2021
ReiterateMorgan Stanley cuts its price target to $19 from $20, keeps Equal-Weight
Sep 13, 2021
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $20
Sep 13, 2021
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight

How other firms rate DOC

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Barclays	Equal Weight	$23	Jul 7, 2026
Raymond James	Mkt Perform		Jun 17, 2026
Morgan Stanley	Equal-Weight	$22	Jun 11, 2026
Evercore ISI	In-line	$21	May 11, 2026
UBS	Neutral	$17	Apr 20, 2026
Argus Research	Hold		Feb 5, 2026
Goldman Sachs	Neutral	$17	Jan 9, 2026
Jefferies	Hold	$17	Dec 16, 2025

Questions about Morgan Stanley and DOC

What is Morgan Stanley's price target for DOC?: Morgan Stanley's latest stated price target for Healthpeak Properties Inc. (DOC) is $22, from its action on Jun 11, 2026.
What is Morgan Stanley's rating on DOC?: Morgan Stanley rates DOC Equal-Weight, a neutral rating, as of Jun 11, 2026.
When did Morgan Stanley last change its view on DOC?: On Jun 11, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $22.
How does Morgan Stanley's DOC target compare with other analysts?: Across 6 firms with a DOC price target in the last 12 months, the median target is $19. Morgan Stanley's $22 is 16% above that.

More DOC rating histories

Raymond James3

All Morgan Stanley ratings DOC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.